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Abstract
Rationale Selective phosphodiesterase (PDE) inhibitors
improve the formation of hippocampus-dependent memo-
ries in several rodent models of cognition. However, studies
evaluating the effects of PDE inhibition on prefrontal
cortex-dependent cognition and in monkeys are rare.
Objectives The present study investigates the effect of the
PDE4 inhibitor rolipram and the PDE5 inhibitor sildenafil
on object retrieval performance. Object retrieval is a
prefrontal cortical-mediated task, which is likely to capture
attention and response inhibition.
Materials and methods The ability to retrieve a food
reward from a clear box with an open side positioned in
various orientations was assessed in adult male cynomolgus
monkeys (Macaca fascicularis).
Results Rolipram (0.003–0.03 mg/kg, intramuscular [i.m.])
and sildenafil (0.3–3 mg/kg, i.m.) dose-dependently increased
correct first reaches during difficult trials, reaching signifi-
cance at 0.01 and 1 mg/kg, respectively. For both drugs,
correct reaches were increased approximately 20%; that is,
performance was improved from ~50 to ~70% correct.
Conclusions Both rolipram and sildenafil improved object
retrieval performance, thus demonstrating the cognition-
enhancing effects of PDE inhibition on a prefrontal task of
executive function in monkeys.
Keywords Attention . Executive function .
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Introduction
Second messenger cyclic nucleotides, i.e., cyclic adeno-
sine monophosphate (cAMP) and cyclic guanosine
monophosphate (cGMP), have been strongly implicated
in processes of synaptic long-term potentiation (LTP;
Frey et al. 1993; Zhuo et al. 1994) and have cognition-
enhancing properties (Bernabeu et al. 1996; Blokland
et al. 2006; Prickaerts et al. 2002a; Prickaerts et al. 2005).
cAMP and cGMP are hydrolyzed by phosphodiesterase
(PDE) enzymes, and inhibitors of PDEs (PDE-Is) produce
cognition-enhancing effects in animal models of cogni-
tion. In this field, research has focused on PDE4 and
PDE5 inhibitors (Blokland et al. 2006; Rose et al. 2005;
Rutten et al. 2006) and more recently PDE2 (Boess et al.
2004; Rutten et al. 2007b) and PDE10 (Rodefer et al.
2005) inhibitors. For example, inhibition of PDE2, PDE4,
and PDE5 can improve memory in the object recognition
task in rodents (Boess et al. 2004; Prickaerts et al. 2004;
Rutten et al. 2007b).
Moreover, the cAMP-selective PDE4-I rolipram is an
effective performance enhancer in the passive avoidance
task (Egawa et al. 1997; Imanishi et al. 1997), fear-
conditioning test (Barad et al. 1998), and radial arm maze
(Zhang and O'Donnell 2000). The cGMP-selective PDE5-I
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sildenafil has been shown to enhance performance in the
object recognition task, in the T-maze, and spatial plus
maze (Devan et al. 2006; Devan et al. 2004; Patil et al.
2006; Prickaerts et al. 2004). In addition, sildenafil
improved object recognition memory in mice (Rutten
et al. 2005), and another PDE5-I, zaprinast, improved
performance in a passive avoidance task in neonatal chicks
(Campbell and Edwards 2006). Taken together, these
results confirm the beneficial effects of PDE inhibition on
cognition involving the hippocampus.
The present study assesses the effects of PDE inhibition
on object retrieval (OR) performance, a task of prefrontal
cognition, in monkeys. OR (also known as the detour
reaching task) involves attention, response inhibition, and
planning (i.e., executive function; Diamond et al. 1989).
Because the prefrontal cortex is not well represented in
rodents (especially the dorsolateral prefrontal cortex) and
considerable debate exists on whether the rodent prefron-
tal cortex subserves the same behavioral functions as the
primate/human prefrontal cortex (Brown and Bowman
2002; Uylings et al. 2003), tests of prefrontal functioning
(i.e., executive function) are preferentially carried out in
monkeys. Successful completion of the OR task requires
various hypothetical steps. An animal must appreciate the
contradiction between visual and tactile input, ignore the
incorrect input, remember the previous incorrect approach,
and formulate a novel approach to obtain the reward,
which acts against the innate tendency of perseveration
toward sustained sensory stimulation (Lipina and
Colombo 2001). Direct support for the involvement of
the frontal cortex in OR comes from studies in which
lesions of the frontal cortex impaired, while lesions of the
hippocampus did not impair, performance in the task
(Diamond et al. 1989; Wilkinson et al. 1997). Further-
more, deficits in OR tasks have been documented in
monkeys after treatment with methylphenyl tetrahydro-
pyridine (Schneider and Roeltgen 1993; Taylor et al.
1990a; Taylor et al. 1990b), phencyclidine (Jentsch et al.
2000; Jentsch et al. 1999a; Jentsch et al. 1999b), and after
excitotoxic lesioning with quinolinic acid of the striatum
(Roitberg et al. 2002). The effect of PDE-Is in the OR task
have, to our knowledge, never been evaluated before in
unimpaired monkeys.
As mentioned above, improvement in hippocampus-
dependent memory tasks in rodents is well established
through PDE inhibition. However, no evidence exists on
the effects of rolipram or sildenafil on prefrontal cortex-
dependent tests of executive function. As the PDE4 enzyme
is omnipresent throughout the brain and PDE5 is expressed
in the hippocampus, cortex, and cerebellum (van Staveren
et al. 2004), we hypothesized that OR performance would




Fourteen adult (age 5–12 years; weights 6–9 kg) male
cynomolgus macaques (Macaca fascicularis) were housed
in same-sex pairs in a colony room maintained at 21±2°C,
40±10% humidity, and on a normal 12-h light/dark cycle
(lights on at 7:00 A.M.). Food (Purina High Protein no.
5045) and water were available ad libitum. All experimen-
tal procedures were approved by the Institutional Animal
Care and Use Committee of Roche Palo Alto and were in
accordance with National Institutes of Health guidelines.
Object retrieval task
The OR task has been previously described by Diamond
et al. (1989). Briefly, this task requires a monkey to reach
into a clear acrylic box (dimensions=5×5×5 cm) with one
open side, to retrieve a food treat (cubes of apple or pear, 1–
2 cm2). The box was positioned in front of the monkey and
outside of the home cage, with the open side facing left,
right, or toward the monkey. Food treats were placed on the
outer edge, inner edge, or deep within the box. A test
session consisted of 17 trials with nine “easy” food
retrievals (i.e., placement of the food reward on the inner
or outer edges of the box or when the opening is toward the
monkey) and eight “difficult” food retrievals (i.e., place-
ment of the food reward deep within the box and the open
side facing left or right, see Fig. 1). The order of
presentation never varied (Table 1), there were no contin-
gencies for incorrect reaches (i.e., monkeys typically
acquired the treat after the incorrect reach) or dropped
treats, and trials were terminated if there were no reaches
within 3 min. The box was cleaned diligently between trials
to minimize cues that could influence the task and
subsequent task performance. After an initial period
(1 week) to acclimatize the monkeys to the apparatus and
procedure, tests were conducted twice a week.
Drugs
Rolipram (0.003, 0.01, 0.03, and 0.1 mg/kg; Sigma
Chemicals, St Louis, MO) and sildenafil (0.3, 1, and
3 mg/kg; Sequoia Research Products Limited, Pangbourne,
UK) were prepared fresh daily in a suspension of 10%
cremaphore/90% saline and administered 30 or 60 min
before testing, respectively. Drugs were administered via
intramuscular injection (i.m.) in a volume of 0.1 ml/kg.
Compounds were typically administered on Tuesday and
Friday each week. Weekly test sessions were comprised of
a vehicle session and a drug test session. Drug administra-
tion and behavioral measurement were completed blind,
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and each drug–dose combination was tested once. Drug
doses were administered in a pseudorandom order.
Data analysis
The mean percent correct first reaches for easy and difficult
food retrievals were analyzed with a one-factor (Dose)
repeated-measures analysis of variance. When significant
effects were demonstrated, a post-hoc Dunnett analysis
comparing dose conditions to vehicle performance was
performed. For all tests, the significance level was 0.05
(two-tailed).
Results
During vehicle sessions, monkeys readily reached for the
food treats, successfully acquiring the treat on the first
reach 100±0% during easy trials and 52±3% during
difficult trials. Over the course of the experiment
(2 months), there were no changes in vehicle performance.
The PDE4 inhibitor rolipram (0.003–0.1 mg/kg, i.m.)
dose-dependently increased correct first reaches during
difficult trials (F[3, 55]=13.5, p<0.05), reaching signifi-
cance at 0.01 mg/kg (Fig. 2a). At the highest dose tested
without side effects (0.03 mg/kg), the percentage correct
first reaches were increased approximately 20 to 71±3%.
Note that at 0.1 mg/kg (data not shown), emesis was
observed in all but two monkeys; these results were
therefore excluded from analysis.
The PDE5 inhibitor sildenafil (0.3–3 mg/kg, i.m.) dose-
dependently increased correct first reaches during difficult
trials (F[3, 50]=8.6, p<0.05), reaching significance at
1 mg/kg (Fig. 2b). At the highest dose tested (3 mg/kg),
correct reaches were increased approximately 20 to 73±3%.
No side effects were observed.
Neither rolipram nor sildenafil altered performance during
the easy trials, with the exception of the high dose of
rolipram (0.1 mg/kg), in which monkeys failed to perform
the task (data not shown) because of emetic side effects.
Discussion
The present study demonstrates performance-enhancing
effects of two selective PDE-Is on OR performance in
monkeys. OR is subserved by the prefrontal cortex and/or
fronto-striatal pathways, within which modulation of
dopamine and acetylcholine transmission are involved in
attention, response inhibition (i.e., executive function), and
working memory in rodents and primates (Jentsch et al.
2000; Lipina and Colombo 2001; Palfi et al. 1996; Ramos
et al. 2003; Wilkinson et al. 1997). To our knowledge, this is
the first study to investigate the effects of PDE5 inhibition on
executive function in monkeys. Of note, two previous studies
have investigated the effects of sildenafil on cognition-related
variables in humans. In these studies, sildenafil was shown to
enhance simple reaction times and to some extent enhance-
ment of focused attention (Grass et al. 2001; Schultheiss
et al. 2001). However, these findings have not been further
Table 1 Primate object retrieval: trial order
Trial number Description Level
1 LOS—line of sight Easy
2 LOS—line of sight Easy
3 RO—right outside Easy
4 RD—right deep Difficult
5 RO—right outside Easy
6 RI—right inside Easy
7 RD—right deep Difficult
8 LO—left outside Easy
9 LD—left deep Difficult
10 LO—left outside Easy
11 LI—left inside Easy
12 LD—left deep Difficult
13 LD—left deep Difficult
14 RD—right deep Difficult
15 LD—left deep Difficult
16 RD—right deep Difficult
17 LOS—line of sight Easy
Fig. 1 A schematic overview of possible trials in the object retrieval
(detour-reaching) task. The transparent box containing a food reward
is depicted form the monkey’s point of view. The top five orientations
depict easy trials, and the bottom two orientations depict difficult trials
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described in the literature. The effects of the PDE4 inhibitor
rolipram on executive function have yet to be assessed in
humans. Thus, the current results complement and extend to
the cognition-enhancing effects of PDE inhibition.
Previous studies have repeatedly shown that PDE-Is can
have cognition-enhancing effects, mainly in hippocampus-
dependent memory tasks, in rodents. For example, the
PDE4 inhibitor rolipram improved long-term memory in
the object recognition task, in passive avoidance learning,
and fear conditioning (Barad et al. 1998; Rutten et al. 2006;
Zhang et al. 2005). In addition, rolipram had performance-
enhancing effects in a prefrontal cortex-dependent working
memory task, i.e., delayed alternation, in young rats and
young monkeys (Ramos et al. 2003). Results from the
present study corroborate the cognition-enhancing effects of
low-dose (0.01 mg/kg) rolipram treatment in a prefrontal
cortex-dependent task, although the present OR task does
not involve working memory but requires attention and
response inhibition (i.e., executive function; Diamond et al.
1989). Furthermore, in aged mice, rolipram ameliorated the
age-related deficits in the passive avoidance task, a test of
hippocampus-dependent memory. In contrast, rolipram
impaired prefrontal cortex-dependent working memory
performance in aged rodents and aged monkeys. With
advancing age, opposite profiles between the function of
protein kinase A (PKA) in the hippocampus and prefrontal
cortex were suggested to explain these results; that is, the
prefrontal cortex showed indices of increased PKA activity,
while the hippocampus exhibited evidence of decreased
PKA activity (Ramos et al. 2003). Although in the present
study, cognition-enhancing effects on executive function
were observed after rolipram treatment in young monkeys,
the possible cognition-impairing effects of rolipram on
prefrontal cortex-dependent tests in aged monkeys should
be further investigated.
Compared to PDE4 inhibition, the cognition-enhancing
effects of PDE5 inhibition have not been studied as
extensively. However, a growing number of studies have
shown cognition-enhancing effects of PDE5-Is in multiple
tests and in multiple species. PDE5-Is improved cognitive
performance in object recognition and inhibitory and
passive avoidance tasks (Baratti and Boccia 1999; Prickaerts
et al. 2005; Prickaerts et al. 2004; Prickaerts et al. 2002b;
Rutten et al. 2005; Shafiei et al. 2006; Singh and Parle
2003). In addition, the inhibition of PDE5 reversed memory
deficits induced by scopolamine, diabetic neuropathy, or
nitric oxide (NO) synthase inhibitors in rats (Devan et al.
2006; Devan et al. 2004; Patil et al. 2004; Prickaerts et al.
1997). To our knowledge, no literature exists on the possible
cognition-enhancing effects of PDE5 inhibitors in nonhuman
primates. Furthermore, the effects of PDE5 inhibition on
prefrontal cortex-depending cognition, i.e., working memory
and executive function, are unknown.
The underlying mechanisms of PDE-Is and cognition
enhancement are still elusive, but several possible pathways
have been described. Possible mechanisms of action for
rolipram and sildenafil are based on the proposed underly-
ing signaling pathways of LTP. Both cAMP and cGMP
have been strongly implicated in hippocampal LTP (Frey et
al. 1993). Activation of LTP-related signaling pathways of
cAMP/PKA/cAMP response element-binding protein
(CREB) and cGMP/protein kinase G (PKG)/CREB have
been implicated as the underlying mechanisms for the
cognition-enhancing effects of PDE4 and PDE5 inhibitors
(Bernabeu et al. 1996; Blokland et al. 2006; Lu and
Hawkins 2002; Prickaerts et al. 2002a; Rutten et al.
2007b). A very recent study suggested another pathway
through which cGMP can influence cognitive processes.
This study showed that the hippocampal NO/cGMP
pathway directly stimulates the postsynaptic cAMP/PKA/
CREB pathway (Matsumoto et al. 2006). Alternatively,
cGMP has also been found to maintain LTP via a
presynaptic cGMP/PKG pathway (Zhuo et al. 1994).
However, the present study involves prefrontal cortex-
dependent behavior, and it remains to be proven that the
above mentioned hippocampal LTP mechanisms of synap-
tical strengthening are also applicable in the prefrontal
cortex. Of note, the effects of rolipram on prefrontal cortex
performance were explained via activation of the postsyn-
aptic PKA pathway (Ramos et al. 2003). Thus, both cGMP
and cAMP can activate cellular cascades resulting in CREB
phosphorylation, which could induce long-lasting changes
in neuronal signaling and may thereby explain the
performance enhancement observed in the present study.
Fig. 2 The effects of PDE-I on
object retrieval (OR) perfor-
mance (mean values and SEM)
a The effects of the PDE4
inhibitor rolipram and the PDE5
inhibitor sildenafil (b) on the
percentage correct first reaches
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Apart from LTP-related mechanisms of action, the
effects of rolipram and sildenafil on prefrontal functioning
in the OR may be explained by their stimulatory effect on
neurotransmission. Because rolipram is independent of a
specific receptor system, it is suggested that rolipram may
ameliorate physiological abnormalities that occur secondary
to alterations in dopaminergic, glutamatergic, serotonergic,
and/or adrenergic transmission (Maxwell et al. 2004;
Rutten et al. 2007a). Elevated cAMP levels are thought to
excite noradrenergic and dopaminergic neurotransmitter
systems (Schoffelmeer et al. 1985), thus enhancing their
availability, hence also enhancing synaptic transmission.
Similar to rolipram, sildenafil is a drug that is not linked to
specific neurotransmitter systems. Modulatory activity of
sildenafil was suggested on central dopaminergic pathways
(Ferrari et al. 2002). Dopaminergic dysfunction in prefron-
tal cortex may subserve at least a component of the
impaired OR/detour performance in deficit models (Jentsch
et al. 1999a). Moreover, serotonin depletions of the
prefrontal cortex in the common marmoset result in deficits
in the acquisition of the OR task (Walker et al. 2006).
Hence, activation of cGMP or cAMP may improve
dopaminergic turnover and prefrontal functioning in the
OR task. Thus far, it remains unclear which of these
abovementioned mechanisms are involved in the prefrontal
cortex and how they explain cognition enhancement by
inhibition of PDEs in the OR task.
To summarize, previous research demonstrated the
cognition- and largely memory-enhancing effects of PDE4
and PDE5 inhibition in rodents. The results from the
current study extend these cognition-enhancing effects of
PDE-Is in rodents to nonhuman primates. More specifically,
rolipram and sildenafil improve OR performance, thus
demonstrating that PDE4 and PDE5 inhibition enhance
performance in a cognitive domain involving executive
function (and attention) mediated by the prefrontal cortex.
Open Access This article is distributed under the terms of the
Creative Commons Attribution NonCommercial License which
permits any noncommercial use, distribution, and reproduction in
any medium, provided the original author(s) and source are credited.
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